{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T09:25:38Z","timestamp":1783416338575,"version":"3.54.6"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,22]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>The aim was to investigate the adverse event reporting patterns of 2 commonly used combined contraceptives (desogestrel\/ethinyl estradiol (DES) and norethisterone\/ethinyl estradiol (NOR)) using the Food and Drug Administration Adverse Event Reporting System database. We selected data from the first quarter of 2004 to the second quarter of 2024 from the Food and Drug Administration Adverse Event Reporting System database for disproportionate analysis. We performed signal detection and comparative analysis using the reporting odds ratio, proportional reporting ratio, Bayesian Confidence Propagation Neural Network, and Empirical Bayes Geometric Mean for adverse events (AEs) related to DES, and NOR. From January 1, 2004 to June 30, 2024, a total of 35,83,091 reports related to drug AEs were extracted. Among these, 1177 reports were associated with DES, involving 4057 AEs; 1677 reports were associated with NOR, involving 4353 AEs. In the category of reproductive system and breast disorders, the reporting association for abnormal withdrawal bleeding was stronger for DES, while withdrawal bleeding and hypomenorrhoea were more frequently reported with NOR. In pregnancy, puerperium, and perinatal conditions, signals for complications of delivery and labor were more prominent in patients using DES. Conversely, NOR showed stronger associations with reports of contraceptive failure (pregnancy during oral contraceptive use and pregnancy while using contraceptives). In vascular disorders, vena cava thrombosis and splenic infarction were reported more frequently in patients using NOR, while arterial thrombosis and embolism were more commonly reported in those using DES. Subgroup analyses showed that women aged 18 to 40 years had a greater number of preferred terms and signal strength in the aforementioned 3 major systems. In this analysis, DES showed stronger reporting signals for arterial thrombosis, perinatal complications, and abnormal withdrawal bleeding, while NOR was more associated with vena cava thrombosis, contraceptive failure, withdrawal bleeding, and breast enlargement. Clinicians may pay particular attention to women of reproductive age, specifically those aged 18 to 40 years.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048669","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T17:00:14Z","timestamp":1779469214000},"page":"e48669","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Comparative adverse event reporting patterns of desogestrel versus norethisterone in third-generation combined oral contraceptives: A disproportionality analysis of the FAERS satabase"],"prefix":"10.1097","volume":"105","author":[{"given":"Jingyu","family":"Li","sequence":"first","affiliation":[{"name":"Department of Gynaecology, The People\u2019s Hospital of Baoan, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Gynaecology, Huanggang Central Hospital, HuangGang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingwei","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Gynaecology, The People\u2019s Hospital of Baoan, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gynaecology, The People\u2019s Hospital of Baoan, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangpei","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Gynaecology, The People\u2019s Hospital of Baoan, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4367-2030","authenticated-orcid":false,"given":"Hongyan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gynaecology, The People\u2019s Hospital of Baoan, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260707","first-page":"1","article-title":"Contraceptive methods women have ever used: United States, 1982-2010.","author":"Daniels","year":"2013","journal-title":"Natl Health Stat Report"},{"key":"R3-20260707","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1001\/jama.2021.21392","article-title":"Contraception selection, effectiveness, and adverse effects: a review.","volume":"326","author":"Teal","year":"2021","journal-title":"JAMA"},{"key":"R4-20260707","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.contraception.2011.04.009","article-title":"Ovulation inhibition doses of progestins: a systematic review of the available literature and of marketed preparations worldwide.","volume":"84","author":"Endrikat","year":"2011","journal-title":"Contraception"},{"key":"R5-20260707","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0015-0282(16)40875-7","article-title":"In vitro action of progestogens on sperm migration in human cervical mucus.","volume":"26","author":"Kesser\u00fc","year":"1975","journal-title":"Fertil Steril"},{"key":"R6-20260707","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/humrep\/13.5.1218","article-title":"Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.","volume":"13","author":"Critchley","year":"1998","journal-title":"Hum Reprod"},{"key":"R7-20260707","doi-asserted-by":"crossref","first-page":"e19266","DOI":"10.2196\/19266","article-title":"Complementing the US food and drug administration adverse event reporting system with adverse drug reaction reporting from social media: comparative analysis.","volume":"6","author":"Zhou","year":"2020","journal-title":"JMIR Public Health Surveill"},{"key":"R8-20260707","doi-asserted-by":"crossref","first-page":"1259908","DOI":"10.3389\/fphar.2023.1259908","article-title":"A pharmacovigilance study of etoposide in the FDA adverse event reporting system(FAERS) database, what does the real world say?","volume":"14","author":"Cui","year":"2023","journal-title":"Front Pharmacol"},{"key":"R9-20260707","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/pds.1001","article-title":"The reporting odds ratio and its advantages over the proportional reporting ratio.","volume":"13","author":"Rothman","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R10-20260707","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.677","article-title":"Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports.","volume":"10","author":"Evans","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R11-20260707","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002280050466","article-title":"A Bayesian neural network method for adverse drug reaction signal generation.","volume":"54","author":"Bate","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"R12-20260707","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00031305.1999.10474456","article-title":"Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system.","volume":"53","author":"DuMouchel","year":"1999","journal-title":"Am Stat"},{"key":"R13-20260707","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(61)91061-3","article-title":"Pulmonary embolism.","volume":"278","author":"Jordan","year":"1961","journal-title":"Lancet"},{"key":"R14-20260707","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case\u2010control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"R15-20260707","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/ije\/21.1.48","article-title":"Risk factors for fatal venousthromboembolism in young women: a case\u2010control study.","volume":"21","author":"Thorogood","year":"1992","journal-title":"Int J Epidemiol"},{"key":"R16-20260707","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral\u2010contraceptive users who are carriers of factor V Leiden mutation.","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"R17-20260707","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ijgo.12455","article-title":"A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception.","volume":"141","author":"Dragoman","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"R18-20260707","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00006254-199211000-00014","article-title":"The new era in oral contraception: pills containing gestodene, norgestimate, and desogestrel.","volume":"47","author":"London","year":"1992","journal-title":"Obstet Gynecol Surv"},{"key":"R19-20260707","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1365-2141.2008.07460.x","article-title":"The relationship between lifestyle factors and venous thromboembolism among women: a report from the MISS study.","volume":"144","author":"Lindqvist","year":"2009","journal-title":"Br J Haematol"},{"key":"R20-20260707","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case\u2010control study.","volume":"339","author":"Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"R21-20260707","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thrombosis: meta\u2010analysis.","volume":"323","author":"Kemmeren","year":"2001","journal-title":"BMJ"},{"key":"R22-20260707","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/17512433.2021.1878876","article-title":"The paradigm of norgestimate: a third-generation testosterone-derivative progestin with a peripheral anti-androgenic activity and the lowest risk of venous thromboembolism.","volume":"14","author":"Grandi","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"key":"R23-20260707","first-page":"CD010813","article-title":"Combined oral contraceptives: venous thrombosis.","volume":"2014","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"R24-20260707","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/0002-9378(92)91397-S","article-title":"Norgestimate: a clinical overview of a new progestin.","volume":"166","author":"Bringer","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"R25-20260707","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2165\/00002018-200225130-00001","article-title":"Oral contraception and the risk of thromboembolism: what does it mean to clinicians and their patients?","volume":"25","author":"Drife","year":"2002","journal-title":"Drug Saf"},{"key":"R26-20260707","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.STR.0000015345.61324.3F","article-title":"Risk of arterial thrombosis in relation to oral contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke.","volume":"33","author":"Kemmeren","year":"2002","journal-title":"Stroke"},{"key":"R27-20260707","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/09513599309152510","article-title":"Efficacy, cycle control and side-effects of two monophasic combination oral contraceptives: gestodene\/ethinylestradiol and norgestimate\/ethinylestradiol.","volume":"7","author":"Affinito","year":"1993","journal-title":"Gynecol Endocrinol"},{"issue":"Suppl","key":"R28-20260707","first-page":"31","article-title":"Comparison of two monophasic oral contraceptives: gestodene\/ethinyl estradiol versus desogestrel\/ethinyl estradiol.","volume":"34","author":"Benagiano","year":"1989","journal-title":"Int J Fertil"},{"key":"R29-20260707","first-page":"CD001016","article-title":"Cyclical progestogens for heavy menstrual bleeding.","volume":"8","author":"Bofill Rodriguez","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R30-20260707","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/s41598-022-05578-0","article-title":"The effectiveness of desogestrel for endometrial protection in women with abnormal uterine bleeding-ovulatory dysfunction: a non-inferiority randomized controlled trial.","volume":"12","author":"Soontrapa","year":"2022","journal-title":"Sci Rep"},{"key":"R31-20260707","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/S0002-9378(89)80006-7","article-title":"Compliance considerations with estrogen replacement: withdrawal bleeding and other factors.","volume":"161","author":"Hahn","year":"1989","journal-title":"Am J Obstet Gynecol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048669","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T09:00:18Z","timestamp":1783414818000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":30,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048669","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"2025-12-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}